4

Respiratory and atopic outcomes in relation to traffic counts in the area of residence

OutcomeCrude reference prevalence % (raw numbers)Exposure tertileCrude prevalence % (raw numbers)Adjusted OR (95% CI)
Asthma10.4 (318/3071)Low9.4 (18/192)0.902 (0.545–1.493)
Medium9.6 (20/208)0.931 (0.576–1.506)
High12.2 (24/197)1.194 (0.762–1.871)
Current asthma#5.0 (157/3124)Low3.1 (6/196)0.607 (0.264–1.396)
Medium5.7 (12/211)1.177 (0.639–2.171)
High8.6 (17/197)1.790 (1.051–3.048)§
Current wheeze#8.6 (266/3085)Low7.3 (14/192)0.848 (0.483–1.488)
Medium8.5 (18/211)1.008 (0.609–1.669)
High13.5 (26/193)1.663 (1.073–2.578)§
Cough18.0 (559/3097)Low18.7 (36/193)1.049 (0.720–1.528)
Medium22.3 (47/211)1.323 (0.942–1.858)
High26.8 (52/194)1.622 (1.162–2.266)ƒ
Hay fever11.7 (360/3082)Low10.9 (21/192)0.940 (0.585–1.510)
Medium12.4 (26/209)1.061 (0.688–1.638)
High13.3 (26/196)1.171 (0.756–1.814)
Skin­prick test 19.4 (341/1762)Low17.9 (20/112)0.846 (0.509–1.405)
≥3 mmMedium18.2 (22/121)0.971 (0.595–1.584)
High23.4 (26/111)1.373 (0.857–2.200)
Pollen13.9 (243/1754)Low14.2 (16/113)0.961 (0.551–1.677)
Medium14.2 (17/120)1.067 (0.619–1.840)
High18.9 (21/111)1.567 (0.940–2.613)+
Specific IgE36.3 (476/1311)Low28.8 (23/80)0.682 (0.411–1.130)
aeroallergensMedium34.7 (34/98)0.933 (0.600–1.453)
≥0.7 kU·mL−1High39.5 (32/81)1.213 (0.755–1.947)
  • OR: odds ratio

  • CI: confidence interval

  • Ig: immunoglobulin

  • low: 2600–15000 vehicles·day−1

  • medium: 15001–30000 vehicles·day−1

  • high: >30000 vehicles·day−1 in street segment <50 m away from home

  • #: with respective symptoms during the last 12 months

  • : morning cough during the last 12months. ORs adjusted for age, sex, socioeconomic status, and family history of asthma, hay fever, or eczema. Traffic categories analysed versus rest of population (reference)

  • +: p=0.05–≤0.10

  • §: p=0.01–≤0.05

  • ƒ: p≤0.01